货号:GS40642
Secukinumab is a fully human monoclonal antibody targeting interleukin-17A (IL-17A). It binds to and neutralizes IL-17A, a key pro-inflammatory cytokine involved in the pathogenesis of immune-mediated diseases. It is approved for the treatment of plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondyloarthritis.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物